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Abstract
Background: The third leading cause of death worldwide is lower 
respiratory tract infection (LRTI), which is considered the most com-
mon condition treated in primary care. The objective of our study is to 
determine the etiological agents that cause viral LRTI in Jordan, aiming 
to help physicians to choose the appropriate treatment strategy.
Materials and Methods: A retrospective study was conducted on 
patients who were admitted with the diagnosis of LRTI between Ja-
nuary 2011 and January 2016. We used Fast-track Diagnostics (FTD)® 
Respiratory 21 Kit (Fast-track Diagnostics, Luxembourg) real-time PCR 
to determine the viral etiology of LRTI, and we investigated pandemic 
H1N1 2009 swine flu (H1N1pdm009) virus using rapid test PCR (RT- 
PCR; Cepheid GeneXpert®, California, USA).
Results: This study involved 495 patients with a mean age of 57.79 
± 18.43 years. The causative agents were identified in 157 patients 
out of 495 patients (31.7%). FTD real-time PCR was done for 170 
patients, and the test was positive for seasonal Influenza A virus in 
7.1% of patients, influenza B in 4.1%, RSV in 4.7%, metapneumovirus 
in 4.1%, adenovirus in 4.1%, coronavirus 229E/NL63 in 4.1%, para-
influenza virus in 7.6%, and rhinovirus in 3.5%. RT- PCR was done 
for 495 patients, and the percent of cases who were positive for 
H1N1pdm009 virus was 4.2%. The rate of ICU admission was 16.8%, 
and the mortality rate of LRTI was as low as 3.6%.
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Introduction
Acute lower respiratory tract infection (LRTI) is the 
most common condition treated in primary care [1], 
and it was considered the third leading cause of 
death worldwide in 2017 [2]. According to recent 
studies, about 1.9 million adults above the age of 
15 die from LRTIs each year [3], with the highest risk 
of mortality among elderly [4-6]. One of the major 
subtypes of LRTI is pneumonia, which is diagnosed 
by the presence of new respiratory symptoms inclu-
ding cough, fever, chills, rigors, chest pain, pleurisy, 
dyspnea and sputum production, and mental status 
changes, and physical exam findings such as respira-
tory rate ≥ 24 breaths/minute, tachycardia, audible 
rales or bronchial sounds, leukocytosis with a left 
shift or leukopenia, in addition to new infiltrate on 
the chest x-ray [7, 8]. Whereas the diagnosis of acu-
te bronchitis is considered when there is no definite 
chest x-ray infiltrate. The annual incidence of pneu-
monia was 24.8 cases per 10,000 adults in the USA 
[9]. The incidence of LRTI differs according to the 
season, occurring more in winter and autumn [10], 
with 20-40% of adults being admitted to hospital 
as a consequence of having pneumonia [11].
Nowadays, viral causes of LRTI are being much 
more recognized. When comparing between con-
ventional viral diagnostic methods (culture, antigen 
detection, and serological assays) and polymera-
se chain reaction (PCR)-based assays, PCR-based 
methods are 2-5 times more sensitive in the de-
tection of respiratory viruses [12]. The use of PCR 
has also increased the detection rate of viruses that 
are difficult to identify with conventional methods, 
including human rhinovirus (HRV), human coronavi-
rus (hCoV), human metapneumovirus (hMPV), and 
human bocavirus [13, 14]. Development of several 
multiplex PCR assays has enabled the simultaneous 
detection of multiple viruses in the same tube. [15]. 
Recently, the utilization of PCR techniques is beco-
ming the standard method of choice for the iden-
tification of respiratory viruses [16-18].
The purpose of this study is to provide epide-
miological data regarding the viral etiology of LRTI 
at our region considering their seasonal variation. 
By this, we will have more understanding of the 
causative agents of LRTI.
Materials and Methods
Data collection and study design
We retrospectively reviewed patients who were 
admitted to Jordan University Hospital (JUH) for 
signs and symptoms of LRTI between January 2011 
and January 2016. We reviewed their medical re-
cords, laboratory results and radiological images. 
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Conclusions: Viral LRTI is more common in winter season in Jordan, 
especially in January. Remarkably, Influenza A and Parainfluenza viru-
ses were the main viral causative agents for LRTI in our study. This 
study suggests that the detection of viral infections in patients with 
LRTI can reduce the use of antibiotics and will slow development of 
antimicrobial resistance.
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Additionally, we reviewed the patients’ symptoms 
and signs elicited during the admission period. We 
documented the patients’ date of admission. We 
took into consideration their gender, smoking ha-
bit (smoker/ non-smoker/ ex-smoker) and co-mor-
bidities, such as diabetes mellitus (DM), pulmonary, 
cardiac, renal, and other co-morbidities. We also 
documented the site of admission, whether ICU 
or floor, also the patient’s status on admission, 
including their level of consciousness, their blood 
pressure, their heart rate and respiratory rate. The 
patient’s blood urea levels and creatinine levels 
were measured, as well as their electrolytes and 
their complete blood count (CBC). We referred to 
the patients’ X-rays, to see if there were radiologic 
changes. We checked the results of the bacterial 
cultures and PCR results from blood samples, bron-
choalveolar lavage fluid (BAL), sputum specimens, 
and nasopharyngeal swabs.
Inclusion and exclusion criteria
Patients above the age of 16 years admitted for LRTI 
under the care of pulmonary medicine and critical 
care primary team were included in this study. Acu-
te bronchitis was defined as having fever (>38°C), 
cough, increased sputum production, rhonchi, and 
wheezing, with no radiographic evidence of pneu-
monia. Pneumonia was defined when the previously 
mentioned symptoms of LRTI were accompanied 
by new or progressive lung infiltrate (i.e., increa-
sed density on chest X-ray due to the presence of 
pus, protein, or air within the parenchyma of the 
lung), consolidation, pleural effusion, or cavitation 
on chest X-ray [19]. We excluded patients diagnosed 
with hospital-acquired, ventilator-associated, and 
healthcare-associated pneumonia [20]. 
Severity and complications of LRTI
Severity of pneumonia was classified according to 
CURB65 mortality predictor for community acquired 
pneumonia, giving 1 point for each of the following 
characteristics: confusion, blood urea nitrogen >7 
mmol/L, respiratory rate >=30 breaths/min, systolic 
blood pressure <=90, diastolic blood pressure =<60 
mmHg, and age 65 years or older. We followed 
up the patients until improvement and hospital dis-
charge or death. Additionally, whether they have 
developed complications, including intubation for 
acute respiratory distress syndrome (ARDS), respira-
tory failure, and other complications like pleural 
effusion, septic shock, while sepsis was defined 
as life-threatening organ dysfunction caused by 
a dysregulated host response to infection [21], 
associated disseminated intravascular coagulation 
(DIC), myocardial infarction (MI), or renal compli-
cations. 
The definition of clinical improvement was based 
on the clinical stability criteria drafted by Infectious 
Diseases Society of America and the American Tho-
racic Society (IDSA/ATS) as the following: patient’s 
temperature ≤ 37 °C (orally), heart rate ≤ 100 beats/
min, respiratory rate ≤ 24 breaths/min, systolic BP ≥ 
90 mmHg, arterial oxygen saturation ≥ 90% or PO2 
≥ 60 mmHg on room air, ability to maintain oral 
intake, and normal or baseline mental status [22].
Laboratory diagnosis of LRTI viral etiology
We used Fast-track Diagnostics (FTD)® Respiratory 
21 Kit (Fast-track Diagnostics, Junglinster, Luxem-
bourg) real-time PCR which included the following 
pathogens: influenza A, influenza B, coronavirus 
NL63, 229E, OC43 and HKU1, parainfluenza 1,2,3 
and 4, human metapneumovirus A and B, rhinovi-
rus, respiratory syncytial viruses A and B, adenovirus, 
enterovirus, parechoovirus, bacovirus, mycloplasma 
pneumonia[23]. In addition, we investigated pande-
mic H1N1 2009 swine flu virus (H1N1pdm009) rapid 
test PCR (RT-PCR; Cepheid GeneXpert®, Sunnyvale, 
California, USA), which is the method of choice for 
its clinical diagnosis [24].
Statistical analysis
For statistical analysis, we used SPSS (SPSS Inc., 
version 22.0, Chicago, Illinois, USA) software for 
analyzing the collected data. The data was analyzed 
using Pearson Chi-squared test (X2 test), as well as 
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T-test. The analysis compared between viral pneu-
monia and acute bronchitis in their etiology, outco-
mes, and mortality rates, taking into considerations 
all other variables. The statistical significance for the 
results in all these two tailed statistical tests was 
considered as P-value < 0.05.
Results
Patients’ characteristics 
This study involved 495 patients with a median age 
of 62 years, and a mean of 57.8 ± 18.4 years. A 
total of 274 (55.4%) patients were males, and 221 
(44.6%) were females. Out of the 495 patients, 
115 were smokers (23.2%), 242 were non-smokers 
(48.9%), 60 were ex-smokers (12.1%), and 78 pa-
tients did not specify their smoking habit (15.8%).
Among the studied population, males showed hig-
her prevalence of smoking (35%), compared with 
only (8%) for female patients. Approximately, 411 
(83%) of the patients have comorbidities (Table 
1). Regarding the clinical diagnosis of these pa-
tients, 290 patients (58.6%) were diagnosed to 
have pneumonia, and 205 (41.4%) were diagno-
sed to have acute bronchitis. The presenting symp-
toms of LRTI varied between patients, but cough 
was reported by 91% of patients, making it the 
most common presenting symptom, followed by 
shortness of breath (SOB) which was reported in 
79.6% of the cases, and sputum production came 
third with a percent of 67.8% (Figure 1). Among 
the 495 patients, 49 patients (9.9%) developed 
complications during their hospitalization period 
(Table 2).
A total of 83 (16.8%) patients were admitted to 
the intensive care unit (ICU) based on their CURB65 
score (mean was 2.1 ±1.0), and/or other factors (e.g. 
bilateral chest X-ray infiltrates, multiple co-morbidi-
ties). Overall, 18 patients (3.6%) have died during 
their hospitalization period.
Table 1. Patients demographics.
Patient Characteristic No. of Patients %
Age (years)
Mean Age + SD (yr) 57.79 ± 18.43 range [16-92]
Median Age 62 years
Gender
Male 274 55.4
Female 221 44.6
Smoking
Current Smoker 115 23.2
Ex-Smoker 60 12.1
Non-Smoker 242 48.9
Unknown 78 15.8
Co-morbidities 411 83.0
Cardiovascular Diseases 272 55.0
Pulmonary diseases 216 43.6
Diabetes Mellitus 191 38.6
Renal Diseases 57 11.5
Other co morbidities 142 28.7
Number of Co-morbidities per patient
No co-morbidities 85 17.2
One co-morbidity 130 26.3
Two co-morbidities 134 27.1
Three co-morbidities 109 22
Four co-morbidities 31 6.3
Five co-morbidities 6 1.2
Figure 1: Patients presenting symptoms.
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Patients presenting symptoms: the most frequent presenting symptoms for 
patients with viral LRTI, with each patient presenting with one or more of the 
mentioned symptoms. All of the patients were evaluated using X-ray.
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Table 3. Causative agents of viral LRTI.
Clinical Characteristics No. of Patients %
Pathogen 157 31.7
Viral 69 13.9
RT-PCR (n=495)
Pandemic H1N1 Swine 22 4.2
FTD (n=170)
Influenza A Seasonal 12 7.1
Influenza B 7 4.1
RSV 8 4.7
metapneumovirus 7 4.1
Adenovirus 7 4.1
Coronavirus 229E/ NL63 7 4.1
Para Influenza 13 7.6
Rhinovirus 6 3.5
Bacteria 105 21.2
The analysis of viral etiology of LRTI over the period of five 
years. FTD real-time PCR was done for 170 patients, while 
RT- PCR was done for 495 patients.
Table 2.  Patients diagnosis, site of admission, CURB-
65 score, and complications.
Clinical Characteristics No. of Patients %
Pneumonia 290 58.6
Bronchitis 205 41.4
Admission
ICU 83 16.8
Ward (in-patient) 412 83.2
Mean CURB-65 score 1.3 ± 0.9
Mean CURB-65 score for ICU 2.1 ± 1.0
Complication 49 9.9
Intubation 10 2.0
Pleural Effusion 26 5.3
septic shock 6 1.2
Renal complications 5 1.0
DIC 2 0.4
MI 4 0.8
Death 18 3.6
The viral etiology results
The causative agents were identified in 157 patients 
(31.7%) (Table 3). We classified the patients accor-
ding to the date of their admission, in order to in-
vestigate seasonal variation (Table 4 & Figure 2). The 
rapid test for H1N1pdm009 virus was done for all 
495 patients and was positive in 22 patients (4.2%).
FTD real-time PCR was done for 170, and the per-
centage of identified viruses were as the following: 
parainfluenza virus was 7.6% (n=13), seasonal In-
fluenza A virus was 7.1% (n=12), influenza B was 
4.1% (n=7), RSV was 4.7% (n=8), metapneumovirus 
was 4.1% (n=7), adenovirus was 4.1% (n=7), coro-
navirus 229E/NL63 was 4.1% (n=7), rhinovirus was 
3.5% (n=6) (Figure 3).
Comparison between pneumonia and 
acute bronchitis
As mentioned earlier, 290 patients (58.6%) were 
diagnosed to have pneumonia, and 205 (41.4%) 
were diagnosed to have acute bronchitis. The me-
dian age of pneumonia patients was 63 years, and 
a mean of 58.7 ± 18.3 years, with (159) 54.8% 
being males, and (131) 45.2% being females. In 
comparison, the median age was 59 years, and the 
mean was 56.6 ± 18.5 years for patients with acute 
bronchitis, with (115) 56.1% being males, and (90) 
43.9% being females. We have discussed the per-
centage of each causative agent for pneumonia and 
acute bronchitis individually in (Table 5). 
Upon analyzing the table, none of the viral cau-
sative agents showed significant difference in the 
number of identified cases between acute bron-
chitis and pneumonia patients, and there was no 
significant seasonal variation between the two 
groups.
ICU cases analysis
From the 495 patients, 83 patients were admit-
ted to the ICU, of which 57 (68.7%) patients were 
pneumonia cases, while the other 26 (31.3%) were 
cases of acute bronchitis. The patients median age 
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Table 4. Monthly distribution of each of the viral causative agents of LRTI over five years.
Characteristic
Month
Month
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
H1N1pdm009 10 2 2 3 0 1 0 1 0 0 2 1 22
Influenza a 5 3 1 0 0 0 0 0 0 1 0 2 12
Influenza B 2 2 0 0 0 0 0 0 0 1 1 1 7
RSV 3 3 1 0 0 0 0 0 0 0 1 0 8
Metapneumovirus 1 2 1 0 0 0 0 0 1 1 1 0 7
Adenovirus 0 1 1 0 1 1 0 0 1 1 1 0 7
Coronavirus 229E/ NL63 0 1 1 0 1 1 0 0 1 1 1 0 7
Parainfluenza virus 2 2 3 1 1 1 0 0 0 2 1 0 13
Rhinovirus 2 2 0 0 0 0 0 0 1 0 0 1 6
Sum 25 18 10 4 3 4 0 1 4 7 8 5 89
This table shows the distribution of cases per month for each of the studied viruses from January 2011 to January 2016.
Table 5.  Monthly distribution of each of the viral 
causative agents of LRTI over five years.
Causative 
Agent
Pneumonia 
(n= 290)
Acute Bronchitis 
(n= 205) P-value
Positive % Positive %
H1N1pdm009 10 3.4 12 5.9 0.201
Influenza A 
Seasonal
8 2.8 4 2.0 0.768
Influenza B 5 1.7 2 1.0 0.717
RSV 5 1.7 3 1.5 0.916
Metapneumovirus 6 2.1 1 0.5 0.292
Adenovirus 4 1.4 3 1.5 0.954
Coronavirus  
229E/ NL63
4 1.4 3 1.5 0.954
Parainfluenza virus 9 3.1 4 2.0 0.646
Rhinovirus 3 1.0 3 1.5 0.865
Sum 25 18 10 4 3
Pearson Chi-squared test (X2 test) was used to calculate 
statistical significance when comparing between the viral 
etiology of pneumonia and acute bronchitis
Figure 2:  Monthly distribution of viral and bacterial 
LRTI.
Monthly distribution of viral and bacterial LRTI: The figure shows the count of 
cases per month over the period of 5 years, showing the increase in viral LRTI 
in autumn and that it peaks in winter.
Figure 3:  Incidence of each viral causative agent 
of LRTI.
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Incidence rates of each viral causative agent of LRTI.
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was 68 years, 51 (61.4%) of them were males, and 
32 (38.6%) were females. The mean CURB65 score 
for ICU patients was 2.1 ± 1.0. The most identified 
causative agent was influenza A (6 cases), followed 
by parainfluenza virus identified in 3 cases, then 
coronavirus 229E/NL63 and adenovirus in two ca-
ses. In addition, influenza B and metapneumovirus 
were identified only in one case of the ICU patients. 
Most of the patients in the ICU have had previous 
co-morbidities. Out of the 83 patients, 79 (95.2%) 
had co-morbidities.
Clinical complications have developed in 22 
(26.5%) cases (p-value <0.001) during their admis-
sion period, and death has been the outcome of 14 
cases out of these 83 cases (16.9%), which means 
that 14 out of the overall 18 death cases (77.8%) 
were ICU patients (p-value <0.001).
Death cases analysis
The overall number of fatalities was 18 (3.6%). 
With 14 cases, the mortality rate in pneumonia ca-
ses (4.8%) was higher than the mortality of acute 
bronchitis (4 cases; 2%). The patients median age 
was 70 years, ten of them were males (55.6%), whi-
le eight were females (44.4%). The mean CURB65 
score of death cases was 2.1 ± 0.8. The identified 
causative agents of death cases have shown that 
the two cases identified to have viral infection were 
cases of poly-microbial infection, since both cases 
were infected with adenovirus, coronavirus, and pa-
rainfluenza virus.
Of the 18 patients who died, 17 had co-morbi-
dities, and10 (55.6%) cases (p-value <0.001) deve-
loped medical complications during their admission 
period.
Discussion
To the best of our knowledge, this is the first 
study to investigate causative agents of viral LRTI 
among Jordanian adults after the outbreak of 
H1N1pdm009 virus. In the course of the initial pha-
se of H1N1pdm009, there was an abrupt upsurge in 
the rate of severe pneumonia and a change in the 
age distribution of patients with such illness [25], 
for which it was essential to investigate the chan-
ges in the pattern and severity of viral LRTI among 
Jordanians, and the changes in the etiology of viral 
respiratory infections.
In our study, the incidence of LRTI was higher in 
male patients, where 55% were males, and 45% 
were females. This may be related to the higher 
smoking percentage among males (35%) compa-
red with female patients (8%) (p-value <0.001). It 
has been confirmed in many studies that smoking 
is an independent risk factor for CAP, and this risk 
increased with the number of pack-years [26-29]. In 
addition, Individuals aged >65 years who had never 
smoked but were exposed to passive smoking were 
also at significantly increased risk of CAP, while this 
effect disappeared in younger individuals [26, 29]. 
In the light of the aforementioned results, additio-
nal studies should be conducted to investigate the 
causative agents of LRTI in smokers, non-smokers, 
ex-smokers, and passive smokers.
Currently, the use of diagnostic methods based 
on PCR have resulted in an increase the sensitivity 
of detecting viral and bacterial pathogens associa-
ted with LRTI [30]. This indicates that PCR is more 
rapid and more sensitive than other viral detection 
techniques [31, 32]. In this study, we attained posi-
tive results in 31.7% of the analyzed patients, with 
13.9% of our patients being positive for viral etiolo-
gy and 21.2% for bacterial etiology. We used rapid 
test-PCR to detect pandemic H1N1pdm009 virus, 
which is the method of choice for the clinical diag-
nosis of swine flu H1N virus in respiratory specimens 
and for differentiating it from seasonal influenza 
viruses [24], and it showed positive results in 4.2% 
of LRTI cases.
Seasonal influenza A virus accounted for appro-
ximately 7.1% of admitted patients with LRTI on 
whom FTD real-time PCR was done. These num-
bers are consistent with incidence of influenza A 
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infection in Thailand, where 7.4% of hospitalized 
CAP patients and 7% in severe CAP patients were 
positive for influenza A [33]. Influenza A was also 
the most common viral pathogen detected in Egyp-
tian patients (8.4%) [34]. Moreover, parainfluenza 
viruses was detected in 7.6% of patients in Jordan, 
which is nearly as Indonesia, where parainfluenza 
virus was detected in (7%) patients [35], and higher 
than the incidence among Egyptian patients (4.2%) 
[34].
RSV is the most common cause of LRTIs in infants 
and young children worldwide [36]. However, RSV 
was identified among 4.7% of our adult patients 
(4.7%). This incidence is higher than those in In-
donesia and USA [9, 35], but lower than that of 
RSV in Jordanian children detected by direct immu-
nofluorescence technique (12.5%) [37]. The lower 
number obtained in this study may be attributed 
to the lower frequency of RSV in Amman, which 
was lower than the prevalence reported in Zarqa 
and in Irbid [38, 39]. This may be due to the diffe-
rence between these cities in geographical location, 
crowding and climatic condition [37]. Furthermore, 
RSV-associated hospitalization rate was found to be 
the highest in children <6 months, for which Middle 
Eastern children with RSV would benefit from futu-
re RSV vaccines and antiviral therapy [40]. 
Each of influenza B, metapneumovirus, adeno-
virus, and coronavirus 229E/NL63 was identified 
in 4.1% of patients in our study, while only 3.5% 
of tested patients were positive for rhinovirus. 
Although rhinovirus is more often detected as the 
causative agents of viral pneumonia, its etiological 
role continues to be questioned [41]. Rhinovirus is 
more commonly detected in asymptomatic patients 
[41], which can explain the low yield in this study 
performed on patients who required hospital ad-
mission.
The association between climate factors and res-
piratory virus infection incidence has been repor-
ted in many previous studies, which mainly focused 
on the low temperature/humidity correlations with 
influenza virus [2, 42]. Additionally, the absolute 
humidity and temperature are also associated with 
hospitalizations due to influenza LRTI [2, 43]. After 
observing the seasonal variation in our study, we 
found that the admission rate for viral LRTI peaked 
in January.
The proportion of hospitalized patients with 
pneumonia who are admitted to the ICU ranges 
between 5 to 20%, depending on hospital and 
health-system characteristics. The CURB-65 score, 
which we used to assess the severity of LRTI among 
our patients, has limited ability in identifying pa-
tients who are at increased risk to deteriorate if they 
were admitted to regular hospital units instead of 
the ICU [44-46]. Furthermore, the guidelines from 
the IDSA-ATS suggests that three or more of nine 
minor criteria should warrant consideration of ICU 
admission (confusion, elevated blood urea nitrogen, 
tachypnea, multilobar infiltrates observed on radio-
graph, hypoxemia, thrombocytopenia, hypotension, 
hypothermia and leukopenia) [46]. In the light of the 
previously mentioned suggestion, we should consi-
der the combination of CURB65 score, the IDSA-
ATS guideline and the clinical status of patients in 
order to ultimately take the final decision of the site 
of patient’s admission.
The average adult in-hospital mortality rate of 
CAP cases worldwide is approximately 10% [47]. In 
the United Kingdom (UK), adult inpatient mortality 
rate of pneumonia is 5-15%.Although patients with 
severe pneumonia requiring intensive care unit (ICU) 
admission, mortality can be as high as 30% [48-51]. 
The mortality rate of LRTI in our study was 3.64%, 
which is very similar to the mortality rate found 
in japan in a study published in 2013, which was 
3.1% [52], while it reached approximately 10% in a 
study done in Germany published in 2006 [53]. The 
low mortality rate in Jordan may be as a result of 
the death of critical patients prior to presentation 
to hospitals, or death soon after presentation of 
symptoms, before specimens can be collected [54]. 
DM was the most common co-morbidity in those 
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patients who died, since it was present in 10 out 
of the 18 patients (55%) who died, and their me-
dian age was 70 years, which raises the concerns 
regarding the severity of pneumonia among elderly 
patients with multiple co-morbidities.
There were several limitations to our study. Firstly, 
FTD was done on 170 (34.34%) patients only, which 
might have focused on patients with more severe 
symptoms. Secondly, only patients who met the 
criteria of inclusion and who were admitted to the 
hospital under the care of the pulmonary medicine 
and critical care primary team were enrolled in the 
study. These two limitations might have restricted 
our study’s sample size and our ability to find fur-
ther correlation of viral causes of respiratory tract 
infection with other medical illnesses. Therefore, we 
suggest performing a multi-center national study to 
involve all admitted patients who meet the inclusion 
criteria from different age groups. In addition, we 
recommend the performance of an international 
study that compares between different geographi-
cal and environmental settings with standardized 
methods of virus isolation and patients’ inclusion 
criteria, in order to have a better understanding of 
the viral etiology of LRTI worldwide.
Conclusion
Lower respiratory tract infection’s causative agents 
vary throughout the year. It is more common in win-
ter season, especially in January. Influenza A and 
parainfluenza viruses were the main causative viral 
agents for LRTI in our study, which highlights the im-
portance of focusing on the administration of seaso-
nal influenza vaccines, especially in elderly patients, 
as well as patients with comorbidities. We suggest 
that early laboratory detection of viral agents in pa-
tients diagnosed with LRTI would help in decreasing 
the usage of antibiotics. This will also help in the 
prevention of antibiotics misuse, which is considered 
the major cause of antimicrobial resistance. 
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